Search - tctmd.com

Displaying 221 - 240 of 2495

Sort: Relevancy | Date

Presentation TCT 2016

Hong Kong Responds: How Would I Treat?

Presenter: Kam-Tim Chan, Afzalur Rahman

October 31, 2016

Presentation TCT 2016

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFpEF

Presenter: Bernard J. Gersh, Valluvan Jeevanandam, JoAnn Lindenfeld, Peter Carson

October 31, 2016

Presentation TCT 2016

Bangladesh Presents: Case 1 Introduction - Complex Left Main Intervention

Presenter: Kam-Tim Chan, Afzalur Rahman

October 31, 2016

Presentation TCT 2016

LEADERS FREE: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Donald Cutlip

October 31, 2016

Presentation TCT 2016

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Presenter: Niall T. Mulvihill, Antoniette Neylon

October 31, 2016

Presentation TCT 2016

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

Presenter: Niall T. Mulvihill

October 31, 2016

Presentation TCT 2016

Trial #3 - The Essentials of ... the LEADERS FREE trial

Presenter: Sunil V. Rao, Harvey D. White, Philip M. Urban

October 31, 2016

Presentation TCT 2016

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEF

Presenter: Bernard J. Gersh, Valluvan Jeevanandam, JoAnn Lindenfeld, Ileana L. Pina

October 31, 2016

Presentation TCT 2016

MATRIX Critique: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Frederick Feit

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 3: The Case for First-line Use of ECMO

Presenter: Simon R. Dixon, Holger Thiele, A. Reshad Garan

October 31, 2016

Presentation TCT 2016

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

Presenter: Sunil V. Rao, Harvey D. White, Salvatore Brugaletta

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 2: The Case for First-line Use of Impella

Presenter: Simon R. Dixon, Holger Thiele, Jerry D Estep

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock Treatment Algorithm 1: The Case for First-line Use of IABP

Presenter: Simon R. Dixon, Holger Thiele, Susan M Joseph

October 31, 2016

Egypt Responds: How Would I Have Treated This Case in My Cath Lab?

Presentation TCT 2016

Egypt Presents: A Case of a Challenging Bifurcation Intervention: How Did I Treat?

Presenter: Mohammad Al-Mutairi, Ricardo Lluberas, Ahmed Magdy, Jorge Villegas, Robaayah Zambahari, Sameh Shaheen

October 31, 2016

Presentation TCT 2016

ABSORB III Critique: Pros and Cons

Presenter: Sunil V. Rao, Harvey D. White, Ron Waksman

October 31, 2016

Presentation TCT 2016

Malaysia Responds: How Would I Have Treated This Case in My Cath Lab?

Presenter: Mohammad Al-Mutairi, Ricardo Lluberas, Ahmed Magdy, Jorge Villegas, Robaayah Zambahari

October 31, 2016

Presentation TCT 2016

Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

Presenter: Sunil V. Rao, Harvey D. White, Stephen G. Ellis

October 31, 2016

Presentation TCT 2016

Acute Cardiogenic Shock: Pathophysiology and Representative Case Presentation

Presenter: Simon R. Dixon, Holger Thiele, Ulrich P. Jorde

October 31, 2016

Presentation TCT 2016

Kuwait Presents: A Case of a Challenging Left Main PCI: How Did I Treat?

Presenter: Mohammad Al-Mutairi, Ricardo Lluberas, Ahmed Magdy, Jorge Villegas, Robaayah Zambahari, Wael Aboushokka

October 31, 2016

Presentation TCT 2016

Uruguay Responds: How Would I Have Treated This Case in My Cath Lab?

Presenter: Mohammad Al-Mutairi, Ricardo Lluberas, Ahmed Magdy, Jorge Villegas, Robaayah Zambahari

October 31, 2016

Advertisement

Hong Kong Responds: How Would I Treat?

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFpEF

Bangladesh Presents: Case 1 Introduction - Complex Left Main Intervention

LEADERS FREE: Pros and Cons

Debate: Should All Low-Risk Patients With Severe Aortic Stenosis Who are Suitable Be Allowed to Choose TAVR Rather than Surgical AVR, Without Further Trial Evidence? Pro Position

Introduction: TAVR in Intermediate-Risk and Low-Risk With Severe Aortic Stenosis

Trial #3 - The Essentials of ... the LEADERS FREE trial

Featured Lecture: Spectrum and Outcomes of Medical and Device-based Therapies for HFrEF

MATRIX Critique: Pros and Cons

Acute Cardiogenic Shock Treatment Algorithm 3: The Case for First-line Use of ECMO

Trial #2 - The Essentials of ... the MATRIX Trial Access Site and Anticoagulation Type (And Infusion Duration) in ACS

Acute Cardiogenic Shock Treatment Algorithm 2: The Case for First-line Use of Impella

Acute Cardiogenic Shock Treatment Algorithm 1: The Case for First-line Use of IABP

Egypt Presents: A Case of a Challenging Bifurcation Intervention: How Did I Treat?

ABSORB III Critique: Pros and Cons

Malaysia Responds: How Would I Have Treated This Case in My Cath Lab?

Trial #1 - The Essentials of ... ABSORB III Everolimus-Eluting Bioresorbable Vascular Scaffolds vs Everolimus-Eluting Metallic Stents in Coronary Artery Disease

Acute Cardiogenic Shock: Pathophysiology and Representative Case Presentation

Kuwait Presents: A Case of a Challenging Left Main PCI: How Did I Treat?

Uruguay Responds: How Would I Have Treated This Case in My Cath Lab?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content